Human blood-based anti-inflammatory solution inhibits osteoarthritis progression in a meniscal-tear rat study.

about

The role of biomaterials in the treatment of meniscal tears.An Autologous Anti-Inflammatory Protein Solution Yielded a Favorable Safety Profile and Significant Pain Relief in an Open-Label Pilot Study of Patients with Osteoarthritis.

P2860

Q44578217-C366F1F4-8FC5-45DE-9015-F45E9B2411C0 Q47137170-1E861AD8-4CDC-4036-9C82-49D1F63B3B85

P2860

Human blood-based anti-inflammatory solution inhibits osteoarthritis progression in a meniscal-tear rat study.

Item

http://www.wikidata.org/entity/Q51161025

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Human blood-based anti-inflamm ...... in a meniscal-tear rat study.

@en

Human blood-based anti-inflamm ...... in a meniscal-tear rat study.

@nl

type

Item

label

Human blood-based anti-inflamm ...... in a meniscal-tear rat study.

@en

Human blood-based anti-inflamm ...... in a meniscal-tear rat study.

@nl

prefLabel

Human blood-based anti-inflamm ...... in a meniscal-tear rat study.

@en

Human blood-based anti-inflamm ...... in a meniscal-tear rat study.

@nl

P1476

Human blood-based anti-inflamm ...... in a meniscal-tear rat study.

@en

P2093

Alison Bendele

http://www.w3.org/2001/XMLSchema#string

Jennifer Woodell-May

http://www.w3.org/2001/XMLSchema#string

Taylor Marohl

http://www.w3.org/2001/XMLSchema#string

William King

http://www.w3.org/2001/XMLSchema#string

P2860

Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist

Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis

Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis

Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors.

The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis.

Anticytokine therapy for osteoarthritis.

A dose response analysis of a specific bone marrow concentrate treatment protocol for knee osteoarthritis.

White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution.

Update on the biology of the chondrocyte and new approaches to treating cartilage diseases.

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

P304

2260-2268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JOR.23528

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28139016

http://www.w3.org/2001/XMLSchema#string

P921

osteoarthritis

Human blood-based anti-inflammatory solution inhibits osteoarthritis progression in a meniscal-tear rat study.

about

P2860

P2860

Human blood-based anti-inflammatory solution inhibits osteoarthritis progression in a meniscal-tear rat study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921